<DOC>
	<DOCNO>NCT00933738</DOCNO>
	<brief_summary>This multi-center study design evaluate heparin insensitivity INRatio Prothrombin Time ( PT ) Monitoring System , utilize INRatio test strip additionally modify low sample volume . The INRatio test strip use quantitative determination PT International Normalized Ratio ( INR ) result fingerstick blood subject oral anticoagulation therapy ( OAT ) warfarin . This study design evaluate accuracy modify INRatio test strip heparin-warfarin bridge therapy unfractionated heparin ( UH ) low molecular weight heparin ( LMWH ) , enoxaparin dalteparin . These INR result compare INR result obtain plasma subject analyzed central laboratory heparin-insensitive reference method : Sysmex CA-560 System . The level UH LMWH plasma sample assess use activate partial thromboplastin time ( aPTT ) anti-factor-Xa assay respectively .</brief_summary>
	<brief_title>Evaluation Accuracy INRatio Prothrombin Time ( PT ) Monitoring System With New Test Strip Oral Anticoagulation Therapy Patient Presence Heparin Low Molecular Weight Heparin ( e.g. , Enoxaparin Dalteparin )</brief_title>
	<detailed_description />
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>Adults ( 18 year age old ) . Willing able provide write informed consent comply study procedure . Receiving warfarin/heparin bridge therapy . Therapy warfarin one heparin list must initiate least 12 hour first study specimen obtain . UH ( last know aPTT prior enrollment ( available† ) must confirm heparin administer ) Dalteparin ( last know antifactor Xa prior enrollment ( available† ) must confirm heparin administer ) Enoxaparin ( last know antifactor Xa prior enrollment ( available† ) must confirm heparin administer ) † If prestudy aPTT antifactor Xa available , subsequent test study phlebotomy phlebotomy part routine medical care take time study phlebotomy must confirm presence heparin ( unfractionated low molecular weight ) order data point include analysis . Exclusion Criteria Known suspect hematocrit le 25 great 55 % ; Autoimmune disorder know interfere INR measurement , lupus antiphospholipid syndrome ( APS ) Already participate specific study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Patients need OAT ( Oral Anticoagulation Therapy )</keyword>
</DOC>